Obafemi Owalowo University
Ile-Ife, Nigeria
NCT Number: NCT02815449
The prevalence of iron deficiency anemia is a wide spread problem in Africa and iron fortification can be an effective strategy to decrease this.
In the current study adding different levels of a stabilizer to iron fortified cubes and it's effect on iron bioavailability from these cubes will be studied in the context of a Nigerian meal in women.
24 Female subjects with low serum ferritin levels will be included in the study. The study will last 64 days and subjects will be asked to consume a breakfast and lunch prepared with a bouillon cube with isotope labeled iron during 3 periods of 5 consecutive days. The absorption of iron will be evaluated after every period and compared between the cubes.
Looking for future studies?
Notify Me18 year–40 year
Female
Interventional
Not applicable
Ile-Ife, Nigeria
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Meals prepared with iron fortified cube with Low stabilizer level
Meals prepared with iron fortified cube with Medium stabilizer level
Meals prepared with iron fortified cube with High stabilizer level
Time frame: 16 days
The amount of iron isotopic label in the blood will be related to the low, medium and high stabilizer level in the cubes to determine whether a dose-response relationship exists.
Time frame: 1, 22, 43 and 64 days
The amount of iron isotopic label in the blood at the end of each administration period plus 14 day incorporation time will be used to calculate the absolute Iron absorption for each stabilizer level
Unilever R&D
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07267975
Anemia, Anemia, Hypochromic
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT06104800
Anemia, Anemia, Hypochromic
México, Mexico
View Trial DetailsNCT03817957
Anemia, Anemia, Hypochromic
Frankfurt, Hessia, Germany
View Trial DetailsNCT06238895
Anemia, Anemia, Hypochromic
Lucerne, Switzerland
View Trial Details